PAUL ADKINS: Open Payments
NPI 1972810802 · WHEELERSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,539 in 169 payments from 34 companies in 2025. Trend: 2023 $5,103 · 2024 $3,237 · 2025 $4,539
Food & beverage: $2,802Speaker / faculty: $1,500Education: $213Travel & lodging: $24
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $1,936 |
| Teva Pharmaceuticals USA, Inc. | 20 | $403 |
| ABBVIE INC. | 25 | $379 |
| Otsuka America Pharmaceutical, Inc. | 11 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $139 |
| Novo Nordisk Inc | 7 | $119 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Janssen Biotech, Inc. | 9 | $100 |
| Amgen Inc. | 5 | $93 |
Products named: BREZTRI, REXULTI, CAPLYTA, VRAYLAR, AIRSUPRA, Kerendia, AUSTEDO XR, QULIPTA.
Industry payments across OH — which companies pay providers there.
